Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Pakming Wong is active.

Publication


Featured researches published by Pakming Wong.


Gastroenterology | 1986

Transformation of inferior vena caval thrombosis to membranous obstruction in a patient with the lupus anticoagulant

Hidetaka Terabayashi; Kunio Okuda; Fumio Nomura; Kunihiko Ohnishi; Pakming Wong

A 24-yr-old woman with hemolytic anemia developed multiple thrombosis of the hepatic vein and inferior vena cava. She was found to have circulating lupus anticoagulant that could have been causally related to the thrombosis and hence the Budd-Chiari syndrome. On her first admission to the hospital vena cava and hepatic vein catheterizations revealed partial thrombotic occlusion of the cava at the level of the diaphragm, which was subsequently transformed into complete membranous obstruction. The right hepatic vein, which was patent on the first admission, was also completely occluded. These observations support the theory that membranous obstruction of the inferior vena cava is a sequela to inferior vena caval thrombosis rather than a congenital anomaly.


Cancer Genetics and Cytogenetics | 1988

Heritable rare fragile sites in patients with leukemia and other hematologic disorders

Motoi Murata; Ei-ichi Takahashi; Masako Minamihisamatsu; Takaaki Ishihara; Pakming Wong; Masami Bessho; Kunitake Hirashima; Tada-aki Hori

Fragile site studies were performed on a total of 126 patients with leukemia and other hematologic disorders including myelodysplastic syndrome (MDS) and polycythemia vera (PV). Compared with an incidence (6.0%) of heritable rare fragile sites in the healthy population, the frequency was not higher in the patient group (3.2%), as a whole. However, two cases of fra(17)(p12) in MDS appeared fourfold larger than expected for this group of patients. In one case, a homozygous carrier of fra(17)(p12) in PV was also very rarely expected from its population incidence. These findings suggested a possible role of rare fragile sites, at least in the etiology of these preleukemic or myeloproliferative disorders.


British Journal of Haematology | 1987

VINBLASTINE-LOADED PLATELET TRANSFUSION IN AN ALLOIMMUNIZED PATIENT

Pakming Wong; Kiyoshi Hiruma; Nobuyuki Endoh; Hirotoshi Nakamura; Kuniaki Itoh; Sho Yoshida; Hisashi Wakita; Takayoshi Asai

Department of Haematology, JEAN-PIERRE N c Stobhill General Hospital, Clasgow G21 3 U W R. L. C. CUMMINC E. H. HORN R. B. HOGC Lefrere. J.J.. Courouche, A.M.. Girot. R. . Bertrand. Y. & Soulier. J.P. (1986) Six cases of hereditary spherocytosis revealed by human parvovirus infection. British journal ojHaernatolog!l. 62 ,65 3-658. Mortimer. P.P. (1983) Hypothesis: The aplastic crisis of hereditary spherocytosis is due to a single transmissible agent. journal oJ Clinical Pathology. 36, 4 4 5 4 4 8 . Mortimer. P.P.. Humphries. R.K.. Moore, J.G.. Purcell. R.H. & Young. N.S. ( 1 983) A human parvovirus-like virus inhibits haematopoietic colony formation in vitro. Nature. 302, 4 2 6 4 2 9 . REFERENCES Cossart. Y.E.. Field, A.M.. Cant, B. & Widdons, D. (1975) Parvoviruslike particles in human sera. Lancet. i, 72-73.


British Journal of Haematology | 1986

DECREASED SERUM 1α,25-DIHYDROXYVITAMIN D3 LEVELS IN LEUKAEMIA

Pakming Wong; Hirotoshi Nakamura; Nobuyuki Endoh; Takayoshi Asai; Kuniaki Itoh; Sho Yoshida

istics of our case deserve additional comments. The myelodysplastic changes seen in apparently non-leukaemic bone marrow cells and the hypoplastic presentation coupled with pancytopenia suggest that AML might have followed a preleukaemic state. Cases of AML following myelodysplastic syndromes (MDS) have been recently recognized (Hehlmann et al, 1981; Eridani et d, 1985; Neame et al, 1985). This, like other evidences (Editorial, 1983), may indicate that some cases of MDS are the result of a defect of the pluripotential stem cell. A hypoplastic presentation has been reported in both AML (Howe et al, 1982) and common ALL (Breatnach et al, 198 1). Hypocellular acute and leukaemia and monosomy 7 are regarded as bad prognostic characteristics in AML (Borgstrom et al, 1980; Howe et ul, 1982). The excellent response to therapy in this patient suggests that intensive post-remission chemotherapy schemes designed for AML might be of value in these cases.


Japanese Journal of Medicine | 1989

Dyslipoproteinemia and an Inhibitor of Lipolytic Enzymes in Weber-Christian Disease

Kohji Shirai; Nobuo Matsuoka; Pakming Wong; Shigenori Fujioka; Yasushi Saito; Sho Yoshida


The Japanese journal of clinical hematology | 1989

[Development of acute myelocytic leukemia in the course of Sjögren's syndrome].

Hisashi Wakita; Takayoshi Asai; Nakamura M; Endoh N; Kiyoshi Hiruma; Igarashi T; Pakming Wong; Kuniaki Itoh; Yoshida S


The American Journal of Medicine | 1988

Pure red cell aplasia induced by alpha-methyldopa

Kuniaki Itoh; Pakming Wong; Takayoshi Asai; Sho Yoshida; Toshio Fukuda


Japanese Journal of Medicine | 1987

Splenic rupture in acute megakaryoblastic leukemia.

Pakming Wong; Katsuhiko Takabayashi; Sugiura Y; Takayoshi Asai; Kuniaki Itoh; Sho Yoshida; Hiroshi Horie


The Japanese journal of clinical hematology | 1987

[Erythrocytosis associated with uterine leiomyoma: a case report].

Kuniaki Itoh; Kiyoshi Hiruma; Hisashi Wakita; Nakamura H; Endoh N; Pakming Wong; Takayoshi Asai; Yoshida S


The Japanese journal of clinical hematology | 1984

A case of acute myeloblastic leukemia with lactic acidosis

Pakming Wong; Igarashi T; Sugiura Y; Takayoshi Asai; Kuniaki Itoh; Osegawa M; Makino H; Fujioka S; Yoshida S

Collaboration


Dive into the Pakming Wong's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Fujioka S

Memorial Hospital of South Bend

View shared research outputs
Researchain Logo
Decentralizing Knowledge